Pathology Doctors in Oxford, MS Accepting Medicare

5 Pathology doctors found. Showing 1 - 5

Dr. Julie Tremor Hicks, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Medicare Enrolled Practice Location: 2301 S Lamar Blvd, Jpb Pathology, Oxford, MS 38655 Phone: 662-232-8125

Dr. William Mason Poston, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Medicare Enrolled Practice Location: 2301 S Lamar Blvd, Oxford, MS 38655 Phone: 662-232-8121    Fax: 662-236-5236

Dr. Rickey Lynn Hicks, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 1100 Belk Blvd, Oxford, MS 38655 Phone: 800-362-0858    Fax: 662-534-7188

Dr. Barbara Proctor, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 1100 Belk Blvd, Oxford, MS 38655 Phone: 901-227-2455

Dr. Jared Cobb, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 1100 Belk Blvd, Oxford, MS 38655 Phone: 662-636-1000

News Archive

SingHealth, Duke-NUS Graduate Medical School join global network to boost healthcare research

SingHealth and Duke-NUS Graduate Medical School, which form Singapore's largest academic healthcare cluster, are joining a new global research network to accelerate the discovery of treatments and cures. They will be signing a memorandum of understanding with the Eureka Institute for Translational Medicine today.

Antiemetic-regimen with fosaprepitant injection provides similar protection against CINV as oral EMEND

Merck announced today results from a new non-inferiority trial of an antiemetic regimen containing fosaprepitant dimeglumine administered as a single intravenous (IV) 150-mg dose in combination with a 5-HT3 antagonist and dexamethasone compared with a three-day regimen of aprepitant with a 5-HT3 antagonist and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving a first cycle of cisplatin-based chemotherapy.

Researchers receive $651,997 funding to study memory dysfunction in MS

Researchers at Montclair State University and Kessler Foundation have received funding totaling $651,997 from the National Multiple Sclerosis Society to measure memory-related abilities in individuals with and without multiple sclerosis (MS) for clues to how such cognitive processes are altered by MS. Joshua Sandry, PhD, assistant professor of psychology at Montclair State and Ekaterina Dobryakova, PhD, research scientist in the Center for Traumatic Brain Injury Research at Kessler Foundation, collaborate on the 4-year study, titled "Neuroimaging of Hippocampally Mediated Memory Dysfunction in Multiple Sclerosis."

SAMHSA: 4.8% U.S. adults suffer from serious mental illness

According to new results from a national survey, 19.9 percent of American adults in the United States (45.1 million) have experienced mental illness over the past year. The survey conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA) indicates that 11 million adults (4.8 percent) in the U.S. suffered serious mental illness in the past year a diagnosable mental disorder has substantially interfered with, or limited one or more major life activities.

CAM use higher among children with GI symptoms: Study

Complementary and alternative medicine is becoming a popular treatment for a variety of conditions, with national data showing it is used by about 12 percent of children.

Read more Medical News

› Verified 5 days ago